|
Roche acquires Medingo Ltd. and expands its position in the growing insulin delivery systems market
|
15 April 2010 |
|
Roche uniquely positioned to deliver long-term growth
|
22 March 2010 |
|
Roche and Biogen Idec decide to suspend Ocrelizumab treatment
|
11 March 2010 |
|
Phase III study of Avastin in advanced stomach cancer did not meet primary endpoint
|
26 February 2010 |
|
US FDA approves Rituxan/MabThera for the most common type of adult leukemia
|
23 February 2010 |
|
Roche study drug may offer valuable new treatment option for patients with type 2 diabetes
|
12 February 2010 |
|
Strong operating performance for Roche in 2009
|
05 February 2010 |
|
Roche establishes new medical research hub in Singapore
|
01 February 2010 |
|
FDA approves ACTEMRA for the treatment of moderately to severely active rheumatoid arthritis
|
13 January 2010 |
|
Herceptin provides impressive survival benefit for patients with high levels of HER2
|
25 September 2009 |
|
Analysis of BRAIN study shows that patients may have a stabilisation or improvement
|
23 September 2009 |
|
Two new studies report increased survival rates in Tamiflu-treated patients
|
15 September 2009 |
|
Roche recognised as new Super Sector Leader in Dow Jones Sustainability Index
|
04 September 2009 |
|
Avastin approved in US for the most common type of kidney cancer
|
03 August 2009 |
|
Xeloda in combination with oxaliplatin shown to be effective in early colon cancer
|
22 July 2009 |
|
Phase III Study Showed Lucentis Improved Vision in Patients with Branch Retinal Vein Occlusion
|
06 July 2009 |
|
Roche announces new two-year data from the LITHE study
|
26 May 2009 |
|
Roche provides additional donation of 5.65 million packs of Tamiflu to WHO
|
14 May 2009 |
|
Roche strongly outperforms market in first quarter
|
22 April 2009 |
|
Roche Diabetes Care supports "Changing Diabetes in Children"
|
16 April 2009 |